Native valve endocarditis due to Candida albicans in two children: Two new case reports.
Gizem GunerZümrüt Şahbudak BalEser DoganZuhal UmitErturk LeventSuleyha Hilmioglu PolatFerda OzkinayZafer KurugolPublished in: Echocardiography (Mount Kisco, N.Y.) (2019)
Candida endocarditis (CE) is a rare and serious complication of candidemia. Using current diagnostic tools a confirmed diagnosis is often delayed and outcomes remain poor. The majority of new cases occur following cardiac valvular surgery, and/or in patients with the following risk factors: intravenous drug use, cancer chemotherapy, prolonged presence of central venous catheters, and prior history of bacterial endocarditis. It is not a common complication in non-neutropenic patients particularly with the absence of a prosthetic valve, and very few reports in the literature are available. Attempting to add to the limited data, 211 candidemia episodes from 172 nonneutropenic pediatric cases between January 2008 and December 2017 were evaluated. All patients were considered asymptomatic for underlying heart disease. However, 2 (0.9%) patients with a central venous catheter were determined as having endocarditis following echocardiography.
Keyphrases
- candida albicans
- end stage renal disease
- risk factors
- ejection fraction
- aortic valve
- chronic kidney disease
- newly diagnosed
- left ventricular
- peritoneal dialysis
- young adults
- prognostic factors
- pulmonary hypertension
- computed tomography
- escherichia coli
- minimally invasive
- biofilm formation
- adipose tissue
- skeletal muscle
- metabolic syndrome
- atrial fibrillation
- case report
- high dose
- patient reported
- glycemic control
- insulin resistance
- quantum dots